Related Experiment Video
Updated: Jul 8, 2026
10:03
Studying Pre-formed Fibril Induced α-Synuclein Accumulation in Primary Embryonic Mouse Midbrain Dopamine Neurons
Published on: August 16, 2020
Excessive dopamine neuron loss in progressive supranuclear palsy
Karen E Murphy1, Tanya Karaconji, Craig D Hardman
1Prince of Wales Medical Research Institute, Randwick, Australia.
Summary
Progressive supranuclear palsy (PSP) and Parkinson's disease (PD) show different responses to levodopa therapy. PSP involves more widespread dopamine neuron loss in the midbrain, potentially explaining this difference.
Area of Science:
- Neuroscience
- Neurology
- Neurodegenerative Diseases
Background:
- Parkinson's disease (PD) and Progressive Supranuclear Palsy (PSP) are neurodegenerative disorders affecting dopamine pathways.
- Both conditions exhibit neuronal degeneration in the substantia nigra, yet their response to dopaminergic therapy differs significantly.
Purpose of the Study:
- To investigate the neuroanatomical basis for differential levodopa response in PSP versus PD.
- To compare dopamine neuron loss in specific midbrain regions between PSP and PD patients.
Main Methods:
- Comparative analysis of post-mortem brain tissue from PSP and PD patients.
- Quantification of dopamine neuron degeneration in the substantia nigra and extranigral A10 midbrain cell groups.
Main Results:
- While both PSP and PD showed substantia nigra degeneration, PSP exhibited more extensive dopamine neuron loss in extranigral A10 midbrain cell groups compared to PD.
- The A10 cell groups innervate crucial subcortical and cortical areas.
Conclusions:
- Widespread loss of dopamine neurons in extranigral A10 regions in PSP may underlie the diminished response to levodopa therapy.
- These findings highlight distinct patterns of neurodegeneration in PSP and PD, impacting therapeutic outcomes.
Related Concept Videos
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...